Genomics company, Integrated DNA Technologies, is rewriting the future of genomics, pioneering new innovations in a bold move ...

Under the agreement, Jorna will design RNA editing drug sequences using its proprietary protein and RNA generative AI model, which is based on the quantum mechanics-based AI called SkyEngine. Ono will ...

Rona Therapeutics, a biotechnology company pioneering innovative RNA-targeted therapies, announced that the Investigational New Drug (IND) application for RN1871, a small interfering RNA (siRNA) drug ...

Southern RNA is an Australian CDMO specialising in producing nucleic acid products that support the clinical development of ...

Decoy Therapeutics, Inc. (Decoy), a privately held preclinical biopharmaceutical company engineering the next generation of peptide conjugate therapeutics, announces that Massachusetts Institute of ...

In the preceding three months, 5 analysts have released ratings for Nektar Therapeutics NKTR, presenting a wide array of perspectives from bullish to bearish. Summarizing their recent assessments ...

TORONTO, April 10, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive ... Results from this study are expected shortly. Numerous nucleic acid-based therapies are under development ...

Revive Therapeutics is a life sciences company focused on the ... Source: Huayamares SG, Loughrey D, Kim H, Dahlman JE, Sorscher EJ. Nucleic acid-based drugs for patients with solid tumours. Nat Rev ...

Numerous nucleic acid-based therapies are under development for treating ... stress are recognized contributors to cancer initiation and growth.” About Revive Therapeutics Ltd. Revive Therapeutics is ...